ProMetic’s technologies are used to remove pathogens from blood, and extract and recover valuable proteins
from plasma.
ProMetic develops therapeutics to treat blood-related disorders and is a world-leading technology provider and drug developer in the fields of hematology, oncology and nephrology.
2013 ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS
(MAY 8, 2013 10:30AM)
Audio link
2013 ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS PRESENTATION
(The presentation will be available starting 10.45am)
